Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Companion Diagnostic Market. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


The future of the companion diagnostic market looks promising with opportunities in the pharmaceutical and biopharmaceutical companies, and reference lab. The global companion diagnostic market is ex

pected to grow with a CAGR of 20% from 2019 to 2024. The major growth drivers for this market are improvements in regulatory guidelines, growing need for targeted therapies, rising cancer incidence , and increasing collaborations and partnerships for companion diagnostics test development.

A report of more than 150 pages developed to help in your business decisions. Sample figures with some insights are shown below. To learn the scope of, benefits, companies researched and other details of companion diagnostic market report download the report brochure



Companion Diagnostic Market by Segments

Companion Diagnostic Market Trends and Forecast

Companion Diagnostic Market Share
 


The study includes the companion diagnostic market size and forecast for the global companion diagnostic market through 2024, segmented by product and service, technology, indication, end use, and region as follows:

By Product and Service [$M shipment analysis for 2013 – 2024]:
  • Assays & Reagents
  • Software & Services

By Technology [$M shipment analysis for 2013 – 2024]:
  • Polymerase Chain Reaction (PCR)
  • Immunohistochemistry (IHC)
  • In Situ Hybridization (ISH)
  • Next-generation Sequencing
  • Other Technologies

By Indication [$M shipment analysis for 2013 – 2024]:
  • Oncology
  • Neurology
  • Other Indications

By End Use [$M shipment analysis for 2013 – 2024]:
  • Pharmaceutical and Biopharmaceutical Companies
  • Reference Lab
  • Other End Users

By Region [$M shipment analysis for 2013 – 2024]:
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
  • Rest of the World
    • Brazil

Some of the companion diagnostics companies profiled in this report include F. Hoffmann-La Roche, Agilent Technologies, Qiagen, Thermo Fisher Scientific, Abbott Laboratories, Biomérieux, Danaher, Illumina, Myriad Genetics, Arup Laboratories, Sysmex, Hologic, Novartis, Almac Group, and Abnova.

Some of the features of this report:
  • Market size estimates: Global companion diagnostic market size estimation in terms of value ($M) shipment.
  • Trend and forecast analysis: Market trend (2013-2018) and forecast (2019-2024) by segments and region.
  • Segmentation analysis: Global market size by various applications such as by product and service, technology, indication, end use, and region.
  • Regional analysis: Global companion diagnostic market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth opportunities: Analysis on growth opportunities in different applications and regions for companion diagnostics in the global companion diagnostic market.
  • Strategic analysis: This includes M&A, new product development, and competitive landscape for, companion diagnostics in the global companion diagnostic market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

This report answers following 11 key questions:

Q.1. What are some of the most promising potential, high-growth opportunities for the global companion diagnostic market by product and service (assays and reagents and software and services), technology (polymerase chain reaction (PCR), immunohistochemistry (IHC), in situ hybridization (ISH) , next-generation sequencing, and other technologies), indication (oncology, neurology, others, and other indications), end use (pharmaceutical and biopharmaceutical companies, reference lab, and other end user), and region (North America, Europe, Asia-Pacific, and ROW)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which regions will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the drivers and challenges of the companion diagnostic market?
Q.5. What are the business risks and threats to the companion diagnostic market?
Q.6. What are emerging trends in this companion diagnostic market and the reasons behind them?
Q.7. What are some changing demands of customers in the companion diagnostic market?
Q.8. What are the new developments in the companion diagnostic market? Which companies are leading these developments?
Q.9. Who are the major players in this companion diagnostic market? What strategic initiatives are being implemented by key players for business growth?
Q.10. What are some of the competitive products and processes in this companion diagnostics area and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11. What M & A activities have taken place in the last 5 years in companion diagnostic market?
Table of Content

1. Executive Summary

2. Market Background and Classifications
   2.1: Introduction, Background, and Classifications
   2.2: Supply Chain
   2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2013 to 2024
   3.1: Macroeconomic Trends and Forecast
   3.2: Global Companion Diagnostic Market: Trends and Forecast
   3.3: Global Companion Diagnostic Market by Product and Service
   3.3.1: Assays & Reagents
   3.3.2: Software & Services
   3.4: Global Companion Diagnostic Market by Technology
   3.4.1: Polymerase Chain Reaction (PCR)
   3.4.2: Immunohistochemistry (IHC)
   3.4.3: In Situ Hybridization (ISH)
   3.4.4: Next-generation Sequencing
   3.4.5: Other Technologies
   3.5: Global Companion Diagnostic Market by Indication
   3.5.1: Oncology
   3.5.2: Neurology
   3.5.3: Others
   3.6: Global Companion Diagnostic Market by End Use
   3.6.1: Pharmaceutical and Biopharmaceutical Companies
   3.6.2: Reference Lab
   3.6.3: Other End Users

4. Market Trends and Forecast Analysis by Region
   4.1: Global Companion Diagnostic Market by Region
   4.2: North American Companion Diagnostic Market
   4.2.1: Market by Product and Service: Assays & Reagents and Software & Services
   4.2.2: Market by Technology: Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ
             Hybridization (ISH), Next-generation Sequencing, and Other Technologies
   4.2.3: Market by Indication: Oncology, Neurology, and Others
   4.2.4: Market by End Use: Pharmaceutical and Biopharmaceutical Companies, Reference
             Lab, and Other End Users
   4.3: European Companion Diagnostic Market
   4.3.1: Market by Product and Service: Assays & Reagents and Software & Services
   4.3.2: Market by Technology: Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ
             Hybridization (ISH), Next-generation Sequencing, and Other Technologies
   4.3.3: Market by Indication: Oncology, Neurology, and Others
   4.3.4: Market by End Use: Pharmaceutical and Biopharmaceutical Companies, Reference Lab,
             and Other End Users
   4.4: APAC Companion Diagnostic Market
   4.4.1: Market by Product and Service: Assays & Reagents and Software & Services
   4.4.2: Market by Technology: Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ
             Hybridization (ISH), Next-generation Sequencing, and Other Technologies
   4.4.3: Market by Indication: Oncology, Neurology, and Others
   4.4.4: Market by End Use: Pharmaceutical and Biopharmaceutical Companies, Reference Lab,
             and Other End Users
   4.5: ROW Companion Diagnostic Market
   4.5.1: Market by Product and Service: Assays & Reagents and Software & Services
   4.5.2: Market by Technology: Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ
             Hybridization (ISH), Next-generation Sequencing, and Other Technologies
   4.5.3: Market by Indication: Oncology, Neurology, and Others
   4.5.4: Market by End Use: Pharmaceutical and Biopharmaceutical Companies, Reference Lab,
             and Other End Users

5. Competitor Analysis
   5.1: Product Portfolio Analysis
   5.2: Market Share Analysis
   5.3: Operational Integration
   5.4: Geographical Reach
   5.5: Porter’s Five Forces Analysis

6. Growth Opportunities and Strategic Analysis
   6.1: Growth Opportunity Analysis
   6.1.1: Growth Opportunities for Global Companion Diagnostic Market by Product and Service
   6.1.2: Growth Opportunities for Global Companion Diagnostic Market by Technology
   6.1.3: Growth Opportunities for Global Companion Diagnostic Market by Indication
   6.1.4: Growth Opportunities for Global Companion Diagnostic Market by End Use
   6.1.5: Growth Opportunities for Global Companion Diagnostic Market by Region
   6.2: Emerging Trends in Global Companion Diagnostic Market
   6.3: Strategic Analysis
   6.3.1: New Product Development
   6.3.2: Capacity Expansion of Global Companion Diagnostic Market
   6.3.3: Mergers, Acquisitions and Joint Ventures in the Global Companion Diagnostic Market

7. Company Profiles of Leading Players
   7.1: F. Hoffmann-La Roche
   7.2: Agilent Technologies
   7.3: Qiagen
   7.4: Thermo Fisher Scientific
   7.5: Abbott Laboratories
   7.6: Biomérieux
   7.7: Danaher
   7.8: Illumina
   7.9: Myriad Genetics
   7.10: Arup Laboratories
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Companion Diagnostic Market: Trends, Opportunities and Competitive Analysis Full Report $ 4,850
142 figures/charts and 107 tables are provided in this 150 - page report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process. 
 

Please sign in below to get report brochure - Companion Diagnostic Market.

At Lucintel, we respect your privacy and maintain the confidentiality of information / data provided by you
(Please enter your corporate email. * These fields are mandatory )
Have an Account / Returning Visitors?

Follow us on